IN8BIO Inc.

11/25/2024 | Press release | Distributed by Public on 11/25/2024 08:21

INB 200: Fully Enrolled Phase 1 Study of Gene Modified Autologous Gamma Delta (γδ) T Cells in Newly Diagnosed Glioblastoma Multiforme (GBM) Patients Receiving Maintenance[...]